SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
後知後孓
Lv1
40 积分
2021-11-25 加入
最近求助
最近应助
互助留言
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
3天前
已完结
Targeting KRAS in cancer
9天前
已完结
Discovery of novel macrocyclic derivatives as potent and selective cyclin-dependent kinase 2 inhibitors
10天前
已完结
The pharmacologic and toxicologic characterization of the potent and selective KRAS G12D inhibitors ERAS-4693 and ERAS-5024
14天前
已完结
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors
14天前
已完结
Annual review of PROTAC degraders as anticancer agents in 2022
1个月前
已完结
Annual review of PROTAC degraders as anticancer agents in 2022
1个月前
已完结
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery
1个月前
已关闭
A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315
1个月前
已完结
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers
1个月前
已完结
没有进行任何应助
感谢
3天前
感谢
9天前
感谢
10天前
感谢
14天前
感谢
14天前
已有资源【积分已退回】
1个月前
压缩文件,下载不了
1个月前
感谢
1个月前
感谢
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论